India's Healthcare Renaissance

India's healthcare sector is entering its most dynamic decade yet - driven by demographic change, rising incomes, expanding insurance coverage, and a government committed to building the infrastructure of a healthier nation. The opportunity is structural, durable, and immense.

About This Report

Indian healthcare is entering a decisive decade.

Protiviti engaged with industry leaders across the healthcare ecosystem, hospital promoters, healthcare consultants, private equity investors, and senior clinicians. Their voices, combined with public data and policy insights, bring life to the opportunities and challenges that define the industry's journey forward.

This report is not a traditional sectoral analysis. It is an attempt to tell the story of Indian healthcare through the lens of its practitioners, its financiers, and its policy architects. Demand is no longer the question. Execution at scale is.

Download the Full Report

Executive Summary

Five themes define the sector's inflection point

+ EXPAND ALL

1. Structural & Durable Demand

+

Driven by ageing demographics, transition toward chronic diseases, and rising income levels not short-term economic cycles. Demand increasingly favours specialist-led, chronic care models.

2. Uneven, Urban-Centric Supply Expansion

+

Access gaps persist across Tier-2/Tier-3 markets despite regular private investment. Clinician unavailability, working capital blockages, and multi-site operational complexity make execution the limiting factor not capital availability.

3. Depth Outperforms Breadth

+

Focused single and super specialty platforms demonstrate superior capital efficiency, faster breakeven, and more consistent clinical outcomes. These models are proving more replicable and better aligned with India's evolving disease profile.

4. Accountability as a Valuation Driver

+

Transparency around clinical outcomes, pricing, governance, and ESG practices is no longer optional. These factors now directly influence valuation premiums and access to capital.

5. Capital Becoming More Involved and Selective

+

Investors are shifting from passive funding to capital-plus models supporting execution, governance, and operating discipline. Scale is being rewarded, but only where it is accompanied by professionalised systems, robust controls, and consistent outcomes. Winning requires combining vision with execution.

Sector Landscape

$638B

Market size has grown from $110B in 2016 a 21.5% CAGR

 

62%

Of new health policy purchases now come from Tier 2/3 cities, with 83% YoY surge in consultations

 

54.8%

Of total health expenditure is out-of-pocket versus 11.3% in the US and 17.1% in the UK

 

1.6%

Hospital beds per 1,000 population versus 4–5 in developed markets, reflecting a structural supply gap 

 

~50%

Of Indians now covered by health insurance (public + private), up from ~40% in 2023 post Ayushman Bharat expansion

 

1.9%

Government health spending as % of GDP in FY24, up from 1.4% in 2017–18; still well below the global average of ~7%

 

$16.2B

Medical tourism market projected by 2030, with 60–80% cost savings vs Western markets driving demand from Africa, CIS, and Southeast Asia

 

$37B

India's digital health market projected by 2030, driven by AI diagnostics, tele-ICU, and ABDM integration

Conclusion

Shaping the next decade: the four A's

This transformation is not about scaling beds or machines. It is about scaling trust, outcomes, and institutions. The next decade will belong to those who can combine execution with vision, scale with accountability, and capital with conscience.

Supply moving closer to patients via Tier 2/3 expansion, hub-and-spoke diagnostics, and national telemedicine at scale

Rising middle-class incomes, health insurance growth at 18–20% CAGR, and the 2025 GST exemption on individual health premiums improving access for the missing middle

As awareness improves, latent demand is converting into visible utilisation particularly where supply moves closer to patients in non-metro regions

Transparency around clinical outcomes, pricing, governance, and ESG practices directly influencing valuation premiums and sustained capital inflows into the sector

Loading...